Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX10
MSI-H Solid Malignant Tumor
Phase II
A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
HLX20
Advanced Solid Tumors
Phase I

A Phase I Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients with Advanced Solid Tumors

HLX22
Solid Tumor
Phase I
Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2
HLX12
Healthy Male Subjects
Phase I

A Phase I Study Comparinge Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects

HLX07
Advanced Solid Tumors
Phase Ib/II

The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined with Chemotherapy in Advanced Solid Tumors